Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jérôme Hadjadj, Nader Yatim, Laura Barnabei, et al.
Science (2020) Vol. 369, Iss. 6504, pp. 718-724
Open Access | Times Cited: 2876

Showing 1-25 of 2876 citing articles:

Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard, Lindsey B. Rosen, Qian Zhang, et al.
Science (2020) Vol. 370, Iss. 6515
Open Access | Times Cited: 2480
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Mérad, Jérôme C. Martin
Nature reviews. Immunology (2020) Vol. 20, Iss. 6, pp. 355-362
Open Access | Times Cited: 2360
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang, Paul Bastard, Zhiyong Liu, et al.
Science (2020) Vol. 370, Iss. 6515
Open Access | Times Cited: 2164
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749
Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1656
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao, et al.
Nature Medicine (2020) Vol. 26, Iss. 7, pp. 1070-1076
Open Access | Times Cited: 1493
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1419-1440.e23
Open Access | Times Cited: 1374
Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao, Mei Ding, Xiang Dong, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 428-455
Open Access | Times Cited: 1282
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, et al.
Cell (2020) Vol. 184, Iss. 1, pp. 149-168.e17
Open Access | Times Cited: 1243
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam, Florian Wimmers, Chris Ka Pun Mok, et al.
Science (2020) Vol. 369, Iss. 6508, pp. 1210-1220
Open Access | Times Cited: 1146
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison, Lin Tao, Penghua Wang
Trends in Immunology (2020) Vol. 41, Iss. 12, pp. 1100-1115
Open Access | Times Cited: 1101
The T cell immune response against SARS-CoV-2
Paul Moss
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 186-193
Open Access | Times Cited: 1087
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim, Jae Hyun Bae, Hyuk‐Sang Kwon, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 1, pp. 11-30
Open Access | Times Cited: 925
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1401-1418.e18
Open Access | Times Cited: 776
Presence of Genetic Variants Among Young Men With Severe COVID-19
Caspar I. van der Made, Annet Simons, Janneke Schuurs-Hoeijmakers, et al.
JAMA (2020) Vol. 324, Iss. 7, pp. 663-663
Open Access | Times Cited: 757
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson, et al.
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 210-216
Open Access | Times Cited: 731
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Toni Delorey, Carly G.K. Ziegler, Graham Heimberg, et al.
Nature (2021) Vol. 595, Iss. 7865, pp. 107-113
Open Access | Times Cited: 713
SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 685
The immunology and immunopathology of COVID-19
Miriam Mérad, Catherine A. Blish, Federica Sallusto, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1122-1127
Open Access | Times Cited: 681
COVID-19 and the human innate immune system
Joachim L. Schultze, Anna C. Aschenbrenner
Cell (2021) Vol. 184, Iss. 7, pp. 1671-1692
Open Access | Times Cited: 661
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
Rogan A. Grant, Luisa Morales‐Nebreda, Nikolay S. Markov, et al.
Nature (2021) Vol. 590, Iss. 7847, pp. 635-641
Open Access | Times Cited: 655
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux, Thomas Henry, Alexandre Bélot, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102567-102567
Open Access | Times Cited: 652
Single-cell multi-omics analysis of the immune response in COVID-19
Emily Stephenson, Gary Reynolds, Rachel A. Botting, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 904-916
Open Access | Times Cited: 610
Pathological sequelae of long-haul COVID
Saurabh Mehandru, Miriam Mérad
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 194-202
Open Access | Times Cited: 583
A molecular single-cell lung atlas of lethal COVID-19
Johannes C. Melms, Jana Biermann, Huachao Huang, et al.
Nature (2021) Vol. 595, Iss. 7865, pp. 114-119
Open Access | Times Cited: 579
Page 1 - Next Page

Scroll to top